Pharmacologically induced penile erections in the assessment and treatment of erectile impotence: a preliminary study of 100 patients.
Ceylon Med J
;
1997 Jun; 42(2): 72-4
Artículo
en Inglés
| IMSEAR
| ID: sea-49092
ABSTRACT
OBJECTIVE:
To assess and compare the immediate and subsequent response to pharmacologically induced penile erections, using intracavernosal injections of papaverine.DESIGN:
Preliminary, prospective study.SETTING:
Male sexual dysfunction clinic at the National Hospital of Sri Lanka. PATIENTS 100 consecutive patients receiving 20 mg papaverine hydrochloride intracavernosally as the first dose. MAIN OUTCOMEMEASURES:
Assessment of the quality of the erection following the initial injection and determination of the optimum dose to achieve a normal erection; number who elected self-injection at home.RESULTS:
Mean age of the 100 impotent men was 36.6 years and the mean duration of erectile dysfunction 43.9 months. Of men in the third decade 87.5% had a normal erection but only one-third of patients over 50 years showed a normal response. 16 patients had a reasonably well established organic problem. 42% of patients had normal nocturnal or early morning erections. The drop-out rate after the initial injection was 17%, 19% of men had a normal erection with 20 mg papaverine and 67% had a normal response to 20 to 80 mg papaverine. Seven patients continued on the self-injection program. Prolonged erections were experienced by 6% of men (1.9% of injections).CONCLUSIONS:
Intracavernosal injection of papaverine hydrochloride is effective in a dose of 20 to 80 mg.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Papaverina
/
Vasodilatadores
/
Erección Peniana
/
Anciano
/
Humanos
/
Masculino
/
Adulto
/
Disfunción Eréctil
/
Persona de Mediana Edad
Tipo de estudio:
Estudio observacional
Idioma:
Inglés
Revista:
Ceylon Med J
Año:
1997
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS